Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-05 7:16 pm Purchase | 2023-12-27 | 13D | Comera Life Sciences Holdings, Inc. CMRA | Cherington Charles | 45,989,871 66.310% | 32,000,317 (+228.74%) | Filing History |
| 2023-12-22 12:05 pm Unchanged | 2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 1,212,526 19.990% | 0 (Unchanged) | Filing History |
| 2023-09-07 8:05 pm Purchase | 2023-08-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA | Cherington Charles | 13,989,554 37.450% | 8,568,949 (+158.08%) | Filing History |
| 2023-09-07 5:26 pm Purchase | 2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 1,212,526 19.990% | 645,000 (+113.65%) | Filing History |
| 2023-08-25 8:40 pm Purchase | 2023-07-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA | Cherington Charles | 5,420,605 19.990% | 986,195 (+22.24%) | Filing History |
| 2023-01-06 4:36 pm Purchase | 2023-01-02 | 13D | Comera Life Sciences Holdings, Inc. CMRA | Cherington Charles | 4,434,410 18.700% | 2,304,636 (+108.21%) | Filing History |
| 2022-12-14 4:30 pm Purchase | 2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 567,526 11.050% | 567,526 (New Position) | Filing History |
| 2022-09-13 09:42 am Purchase | 2022-05-19 | 13D | Comera Life Sciences Holdings, Inc. CMRA | Cherington Charles | 2,129,774 11.200% | 2,129,774 (New Position) | Filing History |
| 2022-03-16 4:30 pm Sale | 2022-03-09 | 13D | Eterna Therapeutics Inc. BTX | Cherington Charles | 295,668 11.400% | -19,997 (-6.33%) | Filing History |
| 2021-05-13 5:00 pm Purchase | 2021-03-25 | 13D | Eterna Therapeutics Inc. BTX | Cherington Charles | 315,665 15.200% | 315,665 (New Position) | Filing History |